60 related articles for article (PubMed ID: 26842712)
1. Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration.
Takagi K; Miki Y; Tanaka S; Hashimoto C; Watanabe M; Sasano H; Ito K; Suzuki T
Endocr J; 2016; 63(3):287-99. PubMed ID: 26842712
[TBL] [Abstract][Full Text] [Related]
2. NUCB2/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway.
Ning S; Liu C; Wang K; Cai Y; Ning Z; Li M; Zeng L
J Transl Med; 2023 Jun; 21(1):362. PubMed ID: 37277807
[TBL] [Abstract][Full Text] [Related]
3. The Multifaceted Nature of Nucleobindin-2 in Carcinogenesis.
Skorupska A; Lenda R; Ożyhar A; Bystranowska D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073612
[TBL] [Abstract][Full Text] [Related]
4. NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis.
Ji R; Wang Y; Pan D; Han J; Wang Y; Zheng S; Zhao W; Li X; Han C; Zhang L
Cancer Lett; 2024 Jun; 591():216893. PubMed ID: 38636892
[TBL] [Abstract][Full Text] [Related]
5. Nucleobindin-2 consists of two structural components: The Zn
Bystranowska D; Skorupska A; Sołtys K; Padjasek M; Krężel A; Żak A; Kaus-Drobek M; Taube M; Kozak M; Ożyhar A
Comput Struct Biotechnol J; 2021; 19():4300-4318. PubMed ID: 34429849
[TBL] [Abstract][Full Text] [Related]
6. Calnuc-derived nesfatin-1-like peptide is an activator of tumor cell proliferation and migration.
Vignesh R; Aradhyam GK
FEBS Lett; 2023 Sep; 597(18):2288-2300. PubMed ID: 37539786
[TBL] [Abstract][Full Text] [Related]
7. Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.
Liu GM; Xu ZQ; Ma HS
Dis Markers; 2018; 2018():4272064. PubMed ID: 30327690
[TBL] [Abstract][Full Text] [Related]
8. Nesfatin-1 and nesfatin-1-like peptide suppress growth hormone synthesis via the AC/PKA/CREB pathway in mammalian somatotrophs.
Vélez EJ; Unniappan S
Sci Rep; 2020 Oct; 10(1):16686. PubMed ID: 33028951
[TBL] [Abstract][Full Text] [Related]
9. Nesfatin-1 suppresses interleukin-1β-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats.
Jiang L; Xu K; Li J; Zhou X; Xu L; Wu Z; Ma C; Ran J; Hu P; Bao J; Wu L; Xiong Y
Aging (Albany NY); 2020 Jan; 12(2):1760-1777. PubMed ID: 32003758
[TBL] [Abstract][Full Text] [Related]
10. Nesfatin-1 protects PC12 cells against high glucose-induced cytotoxicity via inhibiting oxidative stress, autophagy and apoptosis.
Nazarnezhad S; Rahmati M; Shayannia A; Abbasi Z; Salehi M; Khaksari M
Neurotoxicology; 2019 Sep; 74():196-202. PubMed ID: 31323241
[TBL] [Abstract][Full Text] [Related]
11. Role of Nucleobindin-2 in the Clinical Pathogenesis and Treatment Resistance of Glioblastoma.
Lin IC; Chang CH; Chong YB; Kuo SH; Cheng YW; Lieu AS; Tseng TT; Lin CJ; Tsai HP; Kwan AL
Cells; 2023 Oct; 12(19):. PubMed ID: 37830634
[TBL] [Abstract][Full Text] [Related]
12. NUCB-2/Nesfatin-1 promotes the proliferation of nasopharyngeal carcinoma cells.
Liang Y; Ma Y; Wang K; Xiang M; Yi B
Cancer Cell Int; 2023 Aug; 23(1):181. PubMed ID: 37635259
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and progesterone regulate NUCB2/nesfatin-1 expression and function in GH3 pituitary cells and THESC endometrial cells.
Ha J; Shin J; Seok E; Kim S; Sun S; Yang H
Anim Cells Syst (Seoul); 2023; 27(1):129-137. PubMed ID: 37351263
[TBL] [Abstract][Full Text] [Related]
14. The role of the stemness index-associated signature in the analysis of the tumorigenesis of liver cancer patients of different races.
Liu DH; Wen GM; Song CL; Xu ZJ; Ren F; Zhao ZY; Xia P
Am J Cancer Res; 2023; 13(3):802-817. PubMed ID: 37034207
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NUCB2 suppresses the proliferation, migration, and invasion of rheumatoid arthritis synovial fibroblasts from patients with rheumatoid arthritis in vitro.
Zhang S; Zhang T; Xu Y; Rong G; Jing J
J Orthop Surg Res; 2022 Dec; 17(1):574. PubMed ID: 36585713
[TBL] [Abstract][Full Text] [Related]
16. Does one plus one always equal two? Structural differences between nesfatin-1, -2, and nesfatin-1/2.
Lenda R; Padjasek M; Krężel A; Ożyhar A; Bystranowska D
Cell Commun Signal; 2022 Oct; 20(1):163. PubMed ID: 36280843
[TBL] [Abstract][Full Text] [Related]
17. Nucleobindin-2/nesfatin-1 enhances the cell proliferation, migration, invasion and epithelial-mesenchymal transition in gastric carcinoma.
Ren L; Bao D; Wang L; Xu Q; Xu Y; Shi Z
J Cell Mol Med; 2022 Oct; 26(19):4986-4994. PubMed ID: 36065769
[TBL] [Abstract][Full Text] [Related]
18. Expression of NUCB2/NESF-1 in Breast Cancer Cells.
Kmiecik A; Ratajczak-Wielgomas K; Grzegrzółka J; Romanowicz H; Smolarz B; Dziegiel P
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012443
[TBL] [Abstract][Full Text] [Related]
19. NUCB2: roles in physiology and pathology.
Zhou Q; Liu Y; Feng R; Zhang W
J Physiol Biochem; 2022 Aug; 78(3):603-617. PubMed ID: 35678998
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
